Drugs of the future

Journal

Overview
Identity

Publication Venue For

Tafasitamab: Monoclonal antibody targeting CD19 Treatment of B-cell malignancies. 45:641-651. 2020

Crizanlizumab. 43:489-499. 2018

O-GLCNAC'S role in neurological disorders and its therapeutic implications. 39:561-568. 2014

CFTR potentiator treatment of cystic fibrosis. 37:167-174. 2012

Targeting early events in cystic fibrosis disease pathogenesis. 36:133-140. 2011

[¹²⁵I]-IPM. Radioimmunoconjugator antibody radiolabeling reagent. 16:1004-1007. 1991

International Standard Serial Number (issn)

0377-8282

Electronic International Standard Serial Number (eissn)

2013-0368